Clinical trial
Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide
NCT02588001 is registered in ClinicalTrials.gov with Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide
- Lead sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2015
- Completion date
- March 31, 2021
- Enrollment
- 60 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer